Quick Takeaways
- Nantahala Capital Management, LLC filed SCHEDULE 13G/A for ABEONA THERAPEUTICS INC. Common Stock, $0.01 par value (ABEO).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2025.
Nantahala Capital Management, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for ABEONA THERAPEUTICS INC. Common Stock, $0.01 par value (ABEO)
- Filing Manager
- Nantahala Capital Management, LLC
- Reporting Manager
- Nantahala Capital Management, LLC
- Symbol
- ABEO
- Shares outstanding
- 50,021,031 shares
- Disclosed Ownership
- 4,997,101 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 16:40:27 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 14 Nov 2024
- Next filing
- 06 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Management, LLC disclosed 10% ownership in ABEONA THERAPEUTICS INC. Common Stock, $0.01 par value (ABEO) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 14 Nov 2024.
- Current filing was accepted on 15 May 2025, 16:40.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 10% | 4,997,101 | 0 | 4,997,101 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer | |
| Wilmot B. Harkey | 10% | 4,997,101 | 0 | 4,997,101 | /s/ Wilmot B. Harkey | Wilmot B. Harkey | |
| Daniel Mack | 10% | 4,997,101 | 0 | 4,997,101 | /s/ Daniel Mack | Daniel Mack |